文献速递慢性静脉疾病静脉血栓栓塞

深静脉梗阻情况下浅静脉反流管理的系统综述

A systematic review of management of superficial venous reflux in the setting of deep venous obstruction.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2022-01-20

本系统综述检索1991年至2021年文献,纳入10项回顾性队列研究、共2428例患者2476条肢体,评估浅静脉反流合并深静脉梗阻的同期管理。结果显示对合并深静脉梗阻患者行浅静脉消融似乎是安全的,晚期静脉疾病合并髂静脉梗阻者联合深静脉支架与浅静脉消融结局更好。

要点

  • 10项回顾性队列研究共2428例患者2476条肢体,其中944条肢体同期治疗浅静脉反流与深静脉梗阻。
  • 944条肢体中联合大隐静脉消融与深静脉支架483条(51.2%),单纯消融293条(31%),单纯支架168条(17.8%)。
  • 5项比较不同治疗策略的研究中4项报告联合深静脉支架与浅静脉消融优于单纯消融。

核心结论

  • 现有证据因研究数量有限和样本量小而是弱的,但提示对合并深静脉梗阻患者行浅静脉反流消融是安全的。
  • 晚期静脉疾病合并髂静脉梗阻患者,浅静脉反流消融联合髂静脉梗阻治疗结局更好。
  • 需要更多当代研究确认安全性,并专门研究浅静脉反流消融缓解合并腹股沟以下梗阻患者症状的疗效。

研究设计与样本

  • 系统综述,检索PubMed、Web of Science和Google Scholar,纳入1991年至2021年间评估浅静脉反流与深静脉梗阻同期管理的临床研究。
  • 排除患者少于5例、未说明浅静脉反流干预措施或无随访数据的研究。
  • 纳入10项回顾性队列研究,共2428例患者2476条肢体,其中944条肢体同期治疗浅静脉反流与深静脉梗阻或已知深静脉血栓病史。
  • 10项研究中8项为比较性研究,所有纳入研究均为观察性,采用纽卡斯尔-渥太华量表评估质量。

主要发现

  • 深静脉梗阻水平在多数明确报告中位于腹股沟以上。
  • 平均年龄范围42至65岁,1432例患者(59%)为女性,614条肢体(70%)存在晚期慢性静脉疾病(CEAP临床分级4-6级),两项研究仅报告C6级患者。
  • 944条治疗肢体中,大隐静脉消融联合深静脉支架483条(51.2%),单纯大隐静脉消融293条(31%),单纯深静脉支架168条(17.8%)。
  • 5项比较不同治疗策略的研究中4项报告深静脉支架联合大隐静脉消融结局优于单纯消融。
  • 比较单纯反流患者与合并反流及深静脉梗阻患者行大隐静脉消融的研究未发现临床改善和术后并发症率有显著差异。

关键数值与推荐

  • 纳入标准:评估浅静脉反流与深静脉梗阻同期管理的临床研究,患者不少于5例,说明浅静脉反流干预措施且有随访数据。
  • 排除标准:患者少于5例、未说明浅静脉反流干预措施或无随访数据。
  • 质量评估工具:纽卡斯尔-渥太华量表。

临床怎么用

  • 原文结论提示对合并深静脉梗阻患者行浅静脉反流消融是安全的,但证据因研究数量有限和样本量小而是弱的。
  • 原文结论提示晚期静脉疾病合并髂静脉梗阻患者,浅静脉反流消融联合髂静脉梗阻治疗结局更好。

局限性

  • 现有证据因研究数量有限和样本量小而是弱的。
  • 需要更多当代研究确认安全性,并专门研究浅静脉反流消融缓解合并腹股沟以下梗阻患者症状的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Because of the fear of obliterating the collateral outflow path and thus worsening venous hypertension, many physicians believe that deep venous obstruction (DVO) is a contraindication for the treatment of superficial venous reflux (SVR). In the present review, we have described the available clinical data for this important group of patients. METHODS: A literature search was performed of PubMed, Web of Science, and Google Scholar to identify clinical research studies reported between 1991 and 2021 that had evaluated the concomitant management of SVR and DVO. Studies were excluded if they had included fewer than five patients, had not specified the interventions used to treat SVR, or had no follow-up data available. All the studies included were observational, and their quality was assessed using the Newcastle-Ottawa scale. RESULTS: Ten retrospective cohort studies were included, with a total of 2476 limbs in 2428 patients, with concurrent SVR and DVO or a known history of deep vein thrombosis treated in 944 limbs. Of the 10 studies, 8 were comparative. The level of DVO was suprainguinal, when specified, in most cases. The mean age range was 42 to 65 years, 1432 patients (59%) were women, and advanced chronic venous disease (ie, CEAP [clinical, etiologic, anatomic, pathophysiologic] class 4-6) was present in 614 limbs (70%), with two studies reporting uniquely on C6 patients. Of the 944 limbs treated for concomitant SVR and DVO, a combination of saphenous vein ablative procedures and deep venous stenting was performed in 483 limbs (51.2%), saphenous vein ablative procedures alone in 293 limbs (31%), and deep venous stenting alone in 168 (17.8%). Of the five studies comparing the different treatment strategies to treat concurrent SVR and DVO, four reported better outcomes after a combination of deep venous stenting and saphenous vein ablation compared with ablation alone. Studies comparing the outcomes of saphenous ablation for patients with reflux alone vs patients with concurrent reflux and DVO did not find any significant differences in clinical improvement and postoperative complication rates. CONCLUSIONS: The current evidence is weak owing to the limited number of studies and small sample size but suggests that ablation of SVR is safe for patients with concurrent DVO. Patients with advanced venous disease and iliac vein obstruction had better results when SVR ablation was combined with treatment of iliac vein obstruction. Additional contemporary studies are needed to confirm the safety and specifically investigate the efficacy of SVR ablation in relieving the symptoms of patients with concurrent infrainguinal obstruction.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Benfor B, Peden EK. A systematic review of management of superficial venous reflux in the setting of deep venous obstruction. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 35066218. doi:10.1016/j.jvsv.2021.12.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。